EM

Erica Mann

ALS Limited | Non-Executive Director
Ms Mann is a C-suite executive with a 30-year career across regulated, multi-channel and multi product environment in top DAX, NYSE, NASDAQ pharmaceutical, OTC and FMCG multinationals. Before retiring as an executive, Erica led Bayer's Consumer Health Division, one of the OTC companies. Prior to joining Bayer, she was President and General Manager of Pfizer Nutrition following its acquisition of Wyeth Inc, where she served as Senior Vice President of Global Nutrition. This followed other senior executive roles of other Fortune 500 companies including Eli Lily and Johnson & Johnson. She has held leadership positions in South Africa, Australia, New Zealand, Germany, Switzerland and the US. In addition to her executive experience in the nutrition and health industry, Erica has experience with global and emerging markets across Africa, China, Russia, and Brazil. Erica currently serves as an independent director of Kenvue and DSM-Firmenich. Erica was educated in South Africa and obtained diplomas in analytical chemistry (Tswane University, Pretoria), marketing management (IMM, Johannesburg), and small business development (SBDC -Johannesburg). She is a member of the Sustainability & Innovation Committee.

Company and Role

Company
Title
Tenure
Since
ALQ
ALS Limited
  • Non-Executive Director
2yrs, 5mthMar 2024

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
ALQ
ALS Limited
31/03/265,930N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ALQ
ALS Limited
07/08/25
Buy
5,930$18.220$108,044On-market trade